wire - news in brief




Page not found (Error 404)





Category


Years
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 1 - 50 of 314.
1 2 3 4 5 7 Next »

Microtechnics/Electroengineering - Computer Science/Telecom
23.02.2018
Physics/Materials Science
22.02.2018
Business/Economics - Medicine/Pharmacology
22.02.2018
Family Larsson-Rosenquist Foundation to Finance New Center for Research into Long-Term Effects of Breastfeeding
What are the reasons a mother does or does not breastfeed? What effect does the decision have on the child, the mother, and society? Although there is a lot of scientific evidence for the health benef
Medicine/Pharmacology
22.02.2018
Treatment with Novartis’ Ultibro Breezhaler improved cardiac function in COPD patients with lung hyperinflation
Ultibro Breezhaler provided significant improvements in cardiac and lung function in COPD patients with lung hyperinflation, compared to placebo     CLAIM is the first study to investigate the effect of dual bronchodilation on cardiac function   Data published in the Lancet Respiratory Medicine Basel, February 22, 2018 - Novartis today announced the publication of the CLAIM * study in the Lancet Respiratory Medicine, which demonstrated that trea
Education/Continuing Education - Medicine/Pharmacology
20.02.2018
Medicine/Pharmacology
16.02.2018
Novartis new Cosentyx data confirms robust efficacy and quality of life improvements in scalp psoriasis
Majority of patients with scalp psoriasis on Cosentyx (secukinumab) achieved clear skin (PSSI 90) at Weeks 12 and 24 and improved quality of life   Scalp psoriasis affects 60 million people worldwide - a difficult-to-treat form of psoriasis with a substantial impact on quality of life -   Cosentyx data presented at AAD adds to robust evidence demonstrating sustained efficacy in plaque, nail, palmoplantar and scalp psoriasis as well as psoriatic
History/Archeology - Computer Science/Telecom
16.02.2018
Time Machine in the running to become a FET Flagship
Time Machine in the running to become a FET Flagship
2018 will be a pivotal year for the Venice Time Machine project.
Medicine/Pharmacology - Innovation/Technology
15.02.2018
Improving Health of Children in Nigeria
Improving Health of Children in Nigeria
To improve diagnosis and treatment of children under five, Swiss TPH together with the International Committee of the Red Cross (ICRC) developed the electronic decision support tool ALMANACH.
Physics/Materials Science - Chemistry
15.02.2018
Profitable for both sides
The young company Swiss Hydrogen is located in Fribourg. Here work is under way on competitive high-performance fuel cells that could be used in environmentally friendly vehicles or deployed as stationary power generators.
Medicine/Pharmacology - Administration/Government
14.02.2018
Medicine/Pharmacology - Administration/Government
13.02.2018
Sandoz announces US FDA approval and launch of Glatopa 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Sandoz announces US FDA approval and launch of Glatopa 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis Glatopa 40 mg/mL is a fully substitutable, AP-rated generic
Philosophy - Social Sciences
12.02.2018
Innovation/Technology - Architecture
08.02.2018
Building with waste and recycled
Building with waste and recycled
A residential module fully constructed from reusable, recyclable, and compostable materials: This is the premise for the newest unit in NEST, the modular research and innovation building run by Empa and Eawag in Dübendorf.
Medicine/Pharmacology
08.02.2018
Novartis receives FDA approval for Cosentyx label update to include moderate-to-severe scalp psoriasis
US label updated to include Cosentyx (secukinumab) data in moderate-to-severe scalp psoriasis - one of the difficult-to-treat types of psoriasis   Approximately half of all 125 million patients with
Medicine/Pharmacology - Business/Economics
08.02.2018
Innovation/Technology - Environment/Sustainable Development
06.02.2018
New technology undergoes real-world testing
The Zurich-based power company Energie 360° provides natural gas, biogas, and wood pellets throughout Switzerland.
Media - Philosophy
05.02.2018
High Number of Science Enthusiasts in Switzerland
High Number of Science Enthusiasts in Switzerland
The Science Barometer Switzerland published in 2016 showed a clear picture: Swiss people are interested in science and research, and think they are worth supporting. “This main finding doesn't mean, however, that all Swiss people have the same attitude toward science. A differentiated picture emerges by dividing the population into groups,” explains Julia Metag, professor at the University of Fribourg.
Astronomy
01.02.2018
Astronomy: a Rotating System of Satellite Galaxies Raises Questions
Astronomy: a Rotating System of Satellite Galaxies Raises Questions
Astronomers have examined the distribution and movement of dwarf galaxies in the constellation Centaurus, but their observations do not fit with the standard model of cosmology that assumes the existence of dark matter. The international team of researchers led by the University of Basel reported their findings .
Life Sciences - Medicine/Pharmacology
31.01.2018
Lab-on-a-chip for tracking single bacterial cells
Lab-on-a-chip for tracking single bacterial cells
Researchers at the Biozentrum of the University of Basel, together with researchers from the Max Planck Institute in Dresden, have set up a novel lab-on-a-chip with accompanying automatic analysis software.
Medicine/Pharmacology
31.01.2018
Cancer Patients: Web-Based Help Improves Quality of Life
Cancer Patients: Web-Based Help Improves Quality of Life
A diagnosis of cancer causes huge psychological stress, but many patients do not receive any psychological support.
Medicine/Pharmacology - Life Sciences
31.01.2018
Novartis announces NEJM publication of updated analysis from ELIANA trial showing longer-term durable remissions with Kymriah(TM) in children, young adults with r/r ALL
Novartis announces NEJM publication of updated analysis from ELIANA trial showing longer-term durable remissions with Kymriah(TM) in children, young adults with r/r ALL Analysis of 75 patients with m
Earth Sciences
31.01.2018
Two months in Pyeongchang to study Korean snowfalls
Two months in Pyeongchang to study Korean snowfalls
Josué Gehring is about to spend two months taking part in an international meteorological measurement project in the mountains of South Korea, close to the 2018 Winter Olympics host venues.
Environment/Sustainable Development - Administration/Government
29.01.2018
Calculating the CO2 emissions of biofuels is not enough
A new EU regulation aims to shrink the environmental footprint of biofuels starting in 2021. But an EPFL scientist thinks we should go one step further and take into account all compounds produced at biorefineries, not just biofuel.
Medicine/Pharmacology - Administration/Government
26.01.2018
Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors
Lutathera marks first FDA Approval for a Peptide Receptor Radionuclide Therapy (PRRT)   Advanced Accelerator Applications is a newly established subsidiary of Novartis   Lutathera expands Novartis' n
Medicine/Pharmacology - Business/Economics
26.01.2018
Business/Economics - Medicine/Pharmacology
24.01.2018
Novartis delivered good operational performance and landmark innovation in 2017, entering our next growth phase
Full year sales grew 2% (cc, +1% USD) as strong performance of our growth drivers, including Cosentyx and Entresto , more than offset Gleevec/Glivec generic erosion: Cosentyx grew to USD 2.1 bi
Medicine/Pharmacology - Life Sciences
24.01.2018
Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for patients with rare inherited vision loss
Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for patients with rare inherited vision loss Novartis enters into a licensing and supply agre
Administration/Government - Innovation/Technology
23.01.2018
Life Sciences - Medicine/Pharmacology
23.01.2018
A bacterial powder for quickly stabilizing soils
A bacterial powder for quickly stabilizing soils
EPFL's Laboratory of Soil Mechanics has developed an easily reproducible technique using bacteria and urea to reinforce sandy or gravelly terrain.
Physics/Materials Science
23.01.2018
Life Sciences - Medicine/Pharmacology
23.01.2018
A bacterial powder for quickly stabilizing gravel surfaces
A bacterial powder for quickly stabilizing gravel surfaces
EPFL's Laboratory of Soil Mechanics has developed an easily reproducible technique using bacteria and urea to reinforce sandy or gravelly terrain.
Physics/Materials Science - Chemistry
22.01.2018
Optical Nanoscope Allows Imaging of Quantum Dots
Optical Nanoscope Allows Imaging of Quantum Dots
Physicists have developed a technique based on optical microscopy that can be used to create images of atoms on the nanoscale.
Medicine/Pharmacology - Physics/Materials Science
22.01.2018
Novartis reports erenumab met all primary and secondary endpoints in unique Phase IIIb study in episodic migraine patients who have failed multiple prior preventive treatments
Novartis reports erenumab met all primary and secondary endpoints in unique Phase IIIb study in episodic migraine patients who have failed multiple prior preventive treatments LIBERTY is the first mi
Innovation/Technology - Careers/Employment
19.01.2018
Using haptic feedback joysticks to fly drones
A new joystick developed by startup MotionPilot lets users fly drones with just one hand in a fun, intuitive way.
Physics/Materials Science - Chemistry
18.01.2018
Looking beyond the horizon
Looking beyond the horizon
Michel Calame is Head of the Transport at Nanoscale Interfaces Laboratory at Empa. The name says it all: the physicist aims to conduct research at the interface between physics and biology, where damp systems meet dry electronics and nano-devices display quantum mechanical effects because they are so minuscule.
Innovation/Technology - Life Sciences
18.01.2018
Astronomy - Administration/Government
17.01.2018
Investigation launched
ETH Zurich's Executive Board has launched an investigation into allegations of research misconduct by a professor in the former Institute for Astronomy.
Medicine/Pharmacology - Life Sciences
17.01.2018
Novartis granted US FDA Priority Review for Kymriah(TM) (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL
Filing acceptance marks second Priority Review granted to Kymriah by the FDA for two distinct indications, underscoring the potential of first ever FDA-approved CAR-T therapy   EMA granted accelerate
Medicine/Pharmacology - Environment/Sustainable Development
16.01.2018
Novartis new data reinforces superiority of Cosentyx versus Stelara * in achieving skin clearance for psoriasis patients
Results from CLARITY study show Cosentyx (secukinumab) was significantly more effective than Stelara * (ustekinumab) in delivering clear and almost clear skin at 12 weeks and at 16 weeks Data support findings from the CLEAR study, which found Cosentyx was superior to Stelara * in achieving sustained skin clearance (PASI 90) at 52 weeks Cosentyx is the first and only fully human interleukin-17A (IL-17A) inhibitor that showed sustained skin cleara
Innovation/Technology - Event
11.01.2018
Efficient energy from biowaste - Watt d'Or for PSI and Energie 360°
Efficient energy from biowaste - Watt d’Or for PSI and Energie 360°
Efficiently producing energy from biowaste: A technology developed at PSI and tested in collaboration with the Zurich-based energy provider Energie 360° makes it possible.
Medicine/Pharmacology - Business/Economics
11.01.2018
Sport Sciences - Medicine/Pharmacology
11.01.2018
Life Sciences - Computer Science/Telecom
11.01.2018
Blue Brain Nexus: an open-source tool for data-driven science
Knowledge sharing is an important driving force behind scientific progress. In an open-science approach, EPFL's Blue Brain Project has created and open sourced Blue Brain Nexus that allows the building of data integration platforms.
1 2 3 4 5 7 Next »